Advertisement
CRISPR Therapeutics Says FDA Grants RMAT Designation To CTX130
(RTTNews) - Biopharmaceutical company CRISPR Therapeutics (CRSP) announced Wednesday that the U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation to CTX130, the Company's wholly-owned allogeneic CAR T cell therapy targeting CD70, for the treatment of Mycosis Fungoides and Sézary Syndrome (MF/SS).
Established under the 21st Century Cures Act, RMAT designation is a dedicated program designed to expedite the drug development and review processes for promising pipeline products, including genetic therapies.
Similar to Breakthrough Therapy designation, RMAT designation provides the benefits of intensive FDA guidance on efficient drug development.
For More Such Health News, visit rttnews.com
read more
Vertex Pharma Inks Licensing Agreement To Use CRISPR Therapeutics' Gene Editing Technology
Biotechnology company Vertex Pharmaceuticals, Inc. (VRTX) and gene editing company CRISPR Therapeutics, Inc. (CRSP) announced Monday that they have entered into a new non-exclusive licensing agreement for the use of CRISPR Therapeutics' gene editing technology, known as CRISPR/Cas9, to accelerate the development of Vertex's hypoimmune cell therapies for type 1 diabetes (T1D).
RTTNews
|
827 days ago
FTSE 100 Modestly Lower In Cautious Trade As Investors Await U.S. Tariff Moves
The U.K. stock market is modestly lower Tuesday afternoon as investors await Trump administration's moves on trade pacts with major countries in Europe and elsewhere ahead of the July 9 deadline for reciprocal tariffs.
RTTNews
|
16 minutes ago
Eurozone Manufacturing Sector Contraction Slows In June
Eurozone manufacturing activity contracted at a slower pace in June as output showed a sustained expansion and total new work stabilized ending a 37-month period of decline, final survey data from S&P Global showed on Tuesday. The HCOB manufacturing Purchasing Managers' Index posted 49.5 in June, up from 49.4 in May. This was the highest score since August 2022.
RTTNews
|
21 minutes ago
CAC 40 Drifts Lower As Investors Digest Economic Data, Await Tariff Moves
French stocks are exhibiting weakness on Tuesday amid uncertainty about trade negotiations between the U.S. and major nations in Europe and elsewhere ahead of the July 9 deadline for reciprocal tariffs. Investors are also digesting the region economic data, including reports on eurozone inflation and French manufacturing PMI reading.
RTTNews
|
34 minutes ago
Yen Rises As Japan Tankan Data Adds To BOJ Rate-Hike Prospects
The Japanese yen strengthened against other major currencies in the European session on Tuesday, following the Bank of Japan's Tankan survey indicating that business sentiment among major Japanese firms has improved slightly, which increased the likelihood of additional rate hikes by the Japanese central bank.
RTTNews
|
54 minutes ago
Yen Rises Against Majors
The Japanese yen strengthened against other major currencies in the European session on Tuesday.
The yen rose to a 6-day high of 168.46 against the euro and an 8-day high of 196.80 against the pound, from early lows of 169.66 and 197.76, respectively.
RTTNews
|
1h 23min ago
Sensex, Nifty Close Higher After Choppy Session
Indian shares ended on a positive note on Tuesday after a choppy ride as investors tracked the developments on the trade front ahead of a July 9 deadline for Trump administration's reciprocal tariffs.
According to reports, India is on track to finalise an interim trade agreement with the US as soon as this week.
RTTNews
|
1h 33min ago
Mixed Sentiment In Asian Markets
Sentiment in Asian markets remains mixed amidst uncertainty about U.S. tariffs that kept investor sentiment fragile.
RTTNews
|
2h 25min ago
